Cos DiMaggio

Mr. DiMaggio was the architect of two post 9/11 systems for the early detection of and response to biological attacks combining military and civilian data sources and response capabilities. He consulted on the formulation of a national biodefense strategy, the future of bio detection systems, recovery from a hypothetical biological attack, and revisions to the National Response Plan. Mr. DiMaggio serves on several corporate advisory boards and is a former Vice Chair of the Homeland Security and Defense Business Council Board of Directors.  He has been called upon to speak at conferences and universities on topics as diverse as biodefense, strategic defense, arms control, research and development, entrepreneurship, work-life balance, and community resilience. Mr. DiMaggio is the President and CEO of advisory services firm CD3 Strategies. Most recently, he was the President of BrainGu, a technology company known for its software development platforms and critical mission applications. Prior to that, Mr. DiMaggio was a founder and CEO of The Tauri Group, an award-winning professional services firm focused on protection against chemical, biological, radiological, and nuclear weapons and emerging diseases. He guided that firm from a startup in 2001 to a successful exit as a mid-tier company in 2019. Before starting The Tauri Group, Mr. DiMaggio led national security teams at several government contractors providing analytical and advisory support to arms control, intelligence, emergency preparedness, and missile defense programs. He also served as the principal Strategic Defense Initiative analyst at the Congressional Research Service. He holds a Master of Science degree in Public Policy Analysis and a Bachelor of Arts degree in Planetary Geology, both from the University of Rochester.